US 12161733
Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer
granted A61KA61K31/4025A61K45/06
Quick answer
US patent 12161733 (Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4025, A61K45/06, A61K47/547, A61K49/0052